Workflow
赛托生物(300583) - 2021 Q3 - 季度财报
Sito BioSito Bio(SZ:300583)2021-10-28 16:00

Financial Performance - Revenue for Q3 2021 reached ¥258,468,655.81, an increase of 11.37% year-over-year, and total revenue for the year-to-date was ¥882,076,420.50, up 21.66% compared to the same period last year[3] - Net profit attributable to shareholders for Q3 2021 was ¥12,578,394.22, representing a significant increase of 204.17% year-over-year, with year-to-date net profit at ¥31,582,000.79, up 164.29%[3] - The basic earnings per share for Q3 2021 was ¥0.1178, an increase of 204.34% year-over-year, while the diluted earnings per share also stood at ¥0.1178, up 205.56%[3] - Total operating revenue for Q3 2021 reached CNY 882,076,420.50, an increase of 21.7% compared to CNY 725,008,466.40 in the same period last year[21] - Net profit for Q3 2021 was CNY 30,207,464.49, a significant recovery from a net loss of CNY 59,283,354.55 in the previous year[22] - Earnings per share for Q3 2021 were CNY 0.2978, compared to a loss per share of CNY 0.4595 in the same quarter last year[23] - The company reported a total comprehensive income of CNY 32,562,901.09 for Q3 2021, recovering from a loss of CNY 59,283,354.55 in the previous year[23] Assets and Liabilities - Total assets as of the end of Q3 2021 were ¥3,048,613,279.71, reflecting a growth of 7.30% from the end of the previous year[3] - The company's total assets increased to CNY 3,048,613,279.71, up from CNY 2,841,295,244.66 year-over-year[19] - Total liabilities rose to CNY 1,324,660,962.86, compared to CNY 1,149,916,239.64 in the previous year, indicating a year-over-year increase of 15.2%[19] - The company's equity attributable to shareholders increased to CNY 1,676,693,530.56, up from CNY 1,643,008,784.70[19] - The company’s total equity attributable to shareholders was ¥1,676,693,530.56, a slight increase of 2.05% from the end of the previous year[3] Cash Flow - The company reported a net cash flow from operating activities of ¥34,619,403.71 year-to-date, which is a decrease of 86.45% compared to the same period last year[3] - The net cash flow from operating activities was 34,619,403.71, a decrease of 86.4% compared to 255,467,635.44 in the previous period[26] - Cash inflow from operating activities totaled 650,380,676.22, down 6.9% from 698,176,828.78 in the previous period[26] - Cash outflow from operating activities increased to 615,761,272.51, up 39.0% from 442,709,193.34 in the previous period[26] - The net cash flow from investing activities was -270,485,660.90, worsening from -123,559,294.95 in the previous period[26] - Cash inflow from financing activities was 468,772,392.51, an increase of 15.7% compared to 405,000,000.00 in the previous period[26] - The net cash flow from financing activities improved to 52,683,921.28, compared to -134,660,452.16 in the previous period[26] - The total cash and cash equivalents at the end of the period was 60,765,676.58, down from 157,087,291.42 in the previous period[26] Shareholder Information - Total number of common shareholders at the end of the reporting period is 12,062[11] - The largest shareholder, Shandong Runxin Investment Co., Ltd., holds 37.11% of shares, totaling 39,802,720 shares[11] - The second-largest shareholder, Mi Chaojie, holds 22.79% of shares, totaling 24,448,000 shares[11] Research and Development - Research and development expenses for the year-to-date increased to ¥3,414.07 million, a rise of 36.26% compared to the same period last year, driven by increased project activity[9] - Research and development expenses for Q3 2021 were CNY 34,140,716.76, compared to CNY 25,054,992.89 in the same period last year, marking a 36.3% increase[22] Tax and Other Liabilities - The company reported a significant increase in tax liabilities, with amounts due rising by 241.02% year-over-year to ¥1,064.59 million, reflecting increased business activity[9] - The company received 4,194,489.51 in tax refunds, significantly up from 994,103.21 in the previous period[26] Inventory and Receivables - The company’s accounts receivable increased by 96.40% year-over-year to ¥19,803.34 million, attributed to higher business volume[8] - Accounts receivable increased to ¥198,033,437.81 from ¥100,833,276.47 year-over-year[17] - Inventory as of September 30, 2021, is ¥533,188,364.38, slightly up from ¥532,404,151.77 at the end of 2020[17] Company Plans and Approvals - The company plans to issue A-shares to specific investors, pending approval from the Shenzhen Stock Exchange and the China Securities Regulatory Commission[13] - The company is actively engaging with intermediaries to address inquiries related to the A-share issuance process[14] Reporting and Audit - The company has not undergone an audit for the third quarter report[31] - The report was issued by the board of directors on October 29, 2021[32]